Composite inpatient healthcare supply may retain exemption despite MRP medicine billing, while separate taxable sale characterisation remains disputed...
Working-capital adjustment determines whether software-services transfer-pricing margins fall within the statutory tolerance range, eliminating any ad...
Permanent establishment deductions upheld for expatriate salaries, direct costs and trading losses, while head-office costs require fresh classificati...
Data transmission equipment classification under CTSH 8517 62 remains distinct from residual classification, with exemption evidence requiring scrutin...
Veterinary active pharmaceutical ingredients used to prevent and treat coccidiosis in poultry qualify as drugs and medicines where they have established therapeutic use, regulatory recognition and import licensing as drugs. The inclusive definition of "drug" covers substances used as drug components, so bulk drugs and APIs retain that character when used directly or in formulations. The specific description-based IGST entry for drugs and medicines applies across tariff chapters and prevails over the general entry for organic chemicals. Clopidol (VET) and Amprolium 100% (VET) are therefore taxable at the 5% IGST rate, provided they are not covered by the nil-rate entry.
Veterinary active pharmaceutical ingredients used to prevent and treat coccidiosis in poultry qualify as drugs and medicines where they have established therapeutic use, regulatory recognition and import licensing as drugs. The inclusive definition of "drug" covers substances used as drug components, so bulk drugs and APIs retain that character when used directly or in formulations. The specific description-based IGST entry for drugs and medicines applies across tariff chapters and prevails over the general entry for organic chemicals. Clopidol (VET) and Amprolium 100% (VET) are therefore taxable at the 5% IGST rate, provided they are not covered by the nil-rate entry.
Note: It is a system-generated summary and is for quick reference only.